SK281861B6 - Spôsob racemizácie opticky čistého substrátu 2-terc-butylkarboxamidpiperazínu alebo substrátu bohatého na 2-terc-butylkarboxamidpiperazín, alebo jeho solí a substrát na racemizáciu - Google Patents
Spôsob racemizácie opticky čistého substrátu 2-terc-butylkarboxamidpiperazínu alebo substrátu bohatého na 2-terc-butylkarboxamidpiperazín, alebo jeho solí a substrát na racemizáciu Download PDFInfo
- Publication number
- SK281861B6 SK281861B6 SK1006-96A SK100696A SK281861B6 SK 281861 B6 SK281861 B6 SK 281861B6 SK 100696 A SK100696 A SK 100696A SK 281861 B6 SK281861 B6 SK 281861B6
- Authority
- SK
- Slovakia
- Prior art keywords
- tert
- formula
- substrate
- salt
- potassium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Cephalosporin Compounds (AREA)
- Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19291694A | 1994-02-04 | 1994-02-04 | |
PCT/US1995/001232 WO1995021162A1 (en) | 1994-02-04 | 1995-01-30 | Process for making hiv protease inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
SK100696A3 SK100696A3 (en) | 1997-03-05 |
SK281861B6 true SK281861B6 (sk) | 2001-08-06 |
Family
ID=22711555
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1006-96A SK281861B6 (sk) | 1994-02-04 | 1995-01-30 | Spôsob racemizácie opticky čistého substrátu 2-terc-butylkarboxamidpiperazínu alebo substrátu bohatého na 2-terc-butylkarboxamidpiperazín, alebo jeho solí a substrát na racemizáciu |
Country Status (20)
Country | Link |
---|---|
US (1) | US5663341A (ja) |
EP (1) | EP0741712B1 (ja) |
JP (1) | JPH09508628A (ja) |
KR (1) | KR100337579B1 (ja) |
AT (1) | ATE206407T1 (ja) |
AU (1) | AU691878B2 (ja) |
BR (1) | BR9506727A (ja) |
CA (1) | CA2180947A1 (ja) |
CZ (1) | CZ291774B6 (ja) |
DE (1) | DE69523038T2 (ja) |
ES (1) | ES2161863T3 (ja) |
FI (1) | FI112218B (ja) |
HU (1) | HUT76303A (ja) |
NZ (1) | NZ279734A (ja) |
RO (1) | RO118292B1 (ja) |
RU (1) | RU2135482C1 (ja) |
SK (1) | SK281861B6 (ja) |
TW (1) | TW472047B (ja) |
UA (1) | UA46730C2 (ja) |
WO (1) | WO1995021162A1 (ja) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL110255A (en) * | 1993-07-16 | 1998-12-06 | Merck & Co Inc | Creation and resolution of 2 tert-butylcarboxamidopiprazine |
US5464788A (en) * | 1994-03-24 | 1995-11-07 | Merck & Co., Inc. | Tocolytic oxytocin receptor antagonists |
DE69527683T2 (de) * | 1994-04-22 | 2003-04-10 | Koei Chemical Co., Ltd. | Verfahren zur herstellung von optisch aktivem n-tert-butyl-2-piperazincarboxamidamid |
ATE163642T1 (de) * | 1994-11-04 | 1998-03-15 | Yamakawa Chemical Ind | Verfahren zur herstellung von optisch aktiven piperazinderivaten und zwischenprodukten für ihre herstellung |
ATE226945T1 (de) * | 1995-01-23 | 2002-11-15 | Lonza Ag | Verfahren zur herstellung von 1,4,5,6- tetrahydropyrazin-2-carbonsäureamiden |
US5618937A (en) * | 1995-03-15 | 1997-04-08 | Merck & Co., Inc. | Process to make HIV protease inhibitor from (2S)-4-picolyl-2-piperazine-t-butylcarboxamide |
US5612484A (en) * | 1995-05-18 | 1997-03-18 | Merck & Co., Inc. | Process for making HIV protease inhibitors |
DE19536658C2 (de) * | 1995-09-30 | 1998-02-19 | Degussa | Verfahren zur kontinuierlichen Herstellung von basischen, cyclischen, optisch aktiven alpha-Aminosäuren |
CA2201218C (en) * | 1996-04-23 | 2004-09-28 | Rudolf Fuchs | Process for the preparation of optically active piperazine-2-carboxylic acid derivatives |
US8404690B2 (en) | 2003-02-14 | 2013-03-26 | Merck Serono Sa | Piperazine-2-carboxamide derivatives |
GB0314260D0 (en) | 2003-06-19 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB604185A (en) * | 1940-08-08 | 1948-06-30 | Arthur Mandl | Improvements in electric rectifier systems used in power or control systems such as for follow-up systems |
US3692775A (en) * | 1969-03-17 | 1972-09-19 | Allied Chem | Racemization of d-or l-{60 -amino-caprolactam in the presence of metal ions |
US3852351A (en) * | 1972-10-02 | 1974-12-03 | Fmc Corp | Chlorination of acetoacetamides |
JPH01117869A (ja) * | 1987-10-30 | 1989-05-10 | Hokuriku Seiyaku Co Ltd | 2−アミノメチルピペラジン誘導体 |
CA1340588C (en) * | 1988-06-13 | 1999-06-08 | Balraj Krishan Handa | Amino acid derivatives |
CA2081970C (en) * | 1991-11-08 | 1997-07-08 | Joseph P. Vacca | Hiv protease inhibitors useful for the treatment of aids |
US5413999A (en) * | 1991-11-08 | 1995-05-09 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
MX9308016A (es) * | 1992-12-22 | 1994-08-31 | Lilly Co Eli | Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene. |
-
1995
- 1995-01-27 TW TW084100727A patent/TW472047B/zh not_active IP Right Cessation
- 1995-01-30 AU AU16967/95A patent/AU691878B2/en not_active Ceased
- 1995-01-30 CA CA002180947A patent/CA2180947A1/en not_active Abandoned
- 1995-01-30 CZ CZ19962272A patent/CZ291774B6/cs not_active IP Right Cessation
- 1995-01-30 ES ES95908747T patent/ES2161863T3/es not_active Expired - Lifetime
- 1995-01-30 WO PCT/US1995/001232 patent/WO1995021162A1/en active Search and Examination
- 1995-01-30 HU HU9602143A patent/HUT76303A/hu unknown
- 1995-01-30 RU RU96117468/04A patent/RU2135482C1/ru not_active IP Right Cessation
- 1995-01-30 EP EP95908747A patent/EP0741712B1/en not_active Expired - Lifetime
- 1995-01-30 RO RO96-01576A patent/RO118292B1/ro unknown
- 1995-01-30 AT AT95908747T patent/ATE206407T1/de not_active IP Right Cessation
- 1995-01-30 KR KR1019960704219A patent/KR100337579B1/ko not_active IP Right Cessation
- 1995-01-30 BR BR9506727A patent/BR9506727A/pt active Search and Examination
- 1995-01-30 UA UA96093433A patent/UA46730C2/uk unknown
- 1995-01-30 DE DE69523038T patent/DE69523038T2/de not_active Expired - Fee Related
- 1995-01-30 JP JP7520686A patent/JPH09508628A/ja not_active Withdrawn
- 1995-01-30 NZ NZ279734A patent/NZ279734A/en unknown
- 1995-01-30 SK SK1006-96A patent/SK281861B6/sk unknown
- 1995-06-07 US US08/487,903 patent/US5663341A/en not_active Expired - Fee Related
-
1996
- 1996-08-01 FI FI963054A patent/FI112218B/fi active
Also Published As
Publication number | Publication date |
---|---|
KR100337579B1 (ko) | 2002-11-13 |
CA2180947A1 (en) | 1995-08-10 |
CZ227296A3 (en) | 1997-01-15 |
RO118292B1 (ro) | 2003-04-30 |
DE69523038T2 (de) | 2002-06-06 |
EP0741712B1 (en) | 2001-10-04 |
BR9506727A (pt) | 1997-09-23 |
UA46730C2 (uk) | 2002-06-17 |
CZ291774B6 (cs) | 2003-05-14 |
NZ279734A (en) | 1998-05-27 |
FI963054A0 (fi) | 1996-08-01 |
ATE206407T1 (de) | 2001-10-15 |
AU691878B2 (en) | 1998-05-28 |
AU1696795A (en) | 1995-08-21 |
EP0741712A1 (en) | 1996-11-13 |
JPH09508628A (ja) | 1997-09-02 |
US5663341A (en) | 1997-09-02 |
FI112218B (fi) | 2003-11-14 |
HU9602143D0 (en) | 1996-09-30 |
HUT76303A (en) | 1997-07-28 |
DE69523038D1 (de) | 2001-11-08 |
TW472047B (en) | 2002-01-11 |
SK100696A3 (en) | 1997-03-05 |
FI963054A (fi) | 1996-08-01 |
RU2135482C1 (ru) | 1999-08-27 |
MX9603218A (es) | 1997-07-31 |
WO1995021162A1 (en) | 1995-08-10 |
ES2161863T3 (es) | 2001-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5244901A (en) | 4-pyrimidinecarboxamide derivatives, their preparation and their application in therapy | |
SK281861B6 (sk) | Spôsob racemizácie opticky čistého substrátu 2-terc-butylkarboxamidpiperazínu alebo substrátu bohatého na 2-terc-butylkarboxamidpiperazín, alebo jeho solí a substrát na racemizáciu | |
RU2134263C1 (ru) | Способ получения промежуточных соединений, используемых для синтеза ингибиторов вич-протеазы | |
SK283067B6 (sk) | Spôsob výroby epoxidu | |
FR2702477A1 (fr) | Dérivés de benzoxazine, leur préparation et leur application en thérapeutique. | |
AU676079B2 (en) | Process for making HIV protease inhibitors | |
SK115096A3 (en) | Regiospecific process to make cis-1-amino-2-alkanols | |
SK115396A3 (en) | Regiospecific processes to make cis-1-amino-2-alkanols | |
US8198271B2 (en) | Thiophenediamine derivative having urea structure | |
CA2167183C (en) | Process for making hiv protease inhibitors | |
JP2020186182A (ja) | 標的蛋白質分解誘導化合物 | |
WO2009027601A2 (fr) | Dérivés de pyrazole 3,5-carboxylates, leur préparation et leur application en thérapeutique | |
MXPA96003218A (en) | Procedure for making inhibitors of human immunodeficiency and composite intermediate virus proteas | |
NZ243338A (en) | 4-pyrimidine carboxamide derivatives: preparation and pharmaceutical |